65269-36-5

Upstream product

• 501-53-1 benzyl chloroformate 
• 4696-76-8 kananmycin B 

Downstream Products

• 69783-75-1 1D-N,N'-bis-benzyloxycarbonyl-O⁴-(6-amino-2-benzyloxycarbonylamino-N,O⁴-carbonyl-α-D-2,6-dideoxy-glucopyranosyl)-O⁶-(3-amino-N,O²-carbonyl-O⁴,O⁶-cyclohexane-1,1-diyl-α-D-3-deoxy-glucopyranosyl)-2-deoxy-streptamine 
• 70551-03-0 C₂₈H₄₉N₅O₁₆ 
• 70551-01-8 1,3-di-N-formyl-2',3'',6'-tri-N-acetylkanamycin B 
• 70551-02-9 3-N-formyl-2',3'',6'-tri-N-acetylkanamycin B 
• 70551-00-7 2',3'',6'-tri-N-acetylkanamycin B 
• 66887-96-5 1-N-(1,3-dihydroxy-2-propyl)kanamycin B 
• 69783-62-6 O⁴-(6-amino-2-benzyloxycarbonylamino-N⁶,O⁴-carbonyl-α-D-2,6-dideoxy-glucopyranosyl)-O⁶-(3-amino-N,O²-carbonyl-α-D-3-deoxy-glucopyranosyl)-N,N'-bis-benzyloxycarbonyl-1D-2-deoxy-streptamine 

Relevant academic research and scientific papers

A HIGHLY SELECTIVE N-PROTECTION STRATEGY FOR THE PREPARATION OF 1-N-ALKYLATED KANAMYCIN ANTIBIOTICS

An O to N acyl migration technique has been used to selectively acetylate the amino groups of the aminosugar rings of kanamycins A and B, leaving the amino groups on the 2-deoxy-streptamine ring unprotected.A formylation-deformylation process then convert